HCPCS Code Details - J9250

HCPCS Level II Code
Drugs administered other than oral method, chemotherapy drugs
HCPCS Code J9250
Description

Long description:
Methotrexate sodium, 5 mg

Short description:
Methotrexate sodium inj

HCPCS Modifier1
HCPCS Pricing indicator 51 - Drugs
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code D - Special coverage instructions apply
BETOS2 code O1D - Chemotherapy
HCPCS Action code D - Discontinue procedure or modifier code
Type of service 1 - Medical care
Effective date Effective Apr 01, 2024
Date added Added Jan 01, 1994
Termination date Mar 31, 2024
HCPCS Coding Procedures
  HCPCS Code J9250 has been discontinued effective Apr 01, 2024.

HCPCS Modifiers

In HCPCS Level II, modifiers are composed of two alpha or alphanumeric characters.

Example: E0260-NU - Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress
NU” identifies the hospital bed as new equipment

ASP Drug pricing - J9250

Effective Code Dosage Payment
Limit
Vaccine AWP % Vaccine Limit Infusion AWP % DME infusion limit Blood AWP % Blood limit Clotting factor Note
January 1, 2024 - March 31, 2024 5 MG 0.307 - - - - - -
October 1, 2023 - December 31, 2023 5 MG 0.233 20% - - - - -
Jul 1, 2023 - Sep 30, 2023 5 MG 0.274 20% - - - - -
April 1, 2023 - June 30, 2023 5 MG 0.245 20% - - - - -
5 MG 0.219 - - - - - -

See also

  • HCPCS J9249 · Injection, melphalan (apotex), 1 mg

  • HCPCS J9255 · Injection, methotrexate (accord), not therapeutically equivalent to j9260, 50 mg


1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”